Temperature thresholds in assessment of the clinical course of acquired cold contact Urticaria: A prospective observational one year study

Acta Dermato-Venereologica

Volumn 95, Issue 3, 2015, Pages 278-282

  Martinez Escala, M Estela ^a   Curto Barredo, Laia ^a   Carnero, Lluïsa ^a   Pujol, Ramon M ^a   Gimenez Arnau, Ana M ^a  

^a HOSPITAL DEL MAR   (Spain)

Author keywords

Cold urticaria; Rupatadine; Urticaria

Indexed keywords

RUPATADINE; CYPROHEPTADINE; HISTAMINE H1 RECEPTOR ANTAGONIST;

ACQUIRED COLD URTICARIA; ADULT; ALGORITHM; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTACT URTICARIA; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; MALE; OBSERVATIONAL STUDY; PERCEPTIVE THRESHOLD; PRIORITY JOURNAL; PROSPECTIVE STUDY; TEMPERATURE; TREATMENT RESPONSE; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; CLINICAL PATHWAY; COLD; MIDDLE AGED; PREDICTIVE VALUE; PSYCHOLOGY; TEMPERATURE SENSE; TIME; TREATMENT OUTCOME; URTICARIA;

ADULT; ALGORITHMS; COLD TEMPERATURE; CRITICAL PATHWAYS; CYPROHEPTADINE; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSORY THRESHOLDS; THERMOSENSING; TIME FACTORS; TREATMENT OUTCOME; URTICARIA;

EID: 84916233604     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-1918     Document Type: Article

References (36)

1. Magerl M, Borzova E, Gimenez-Arnau A, Grattan CRH, Lawlor F, Mathelier-Fusade P, et al. The definition and diagnostic testing of physical and cholinergic urticarias– EAACI/GAL2EN/EDF/UNEV consensus panel recommendations. Allergy 2009; 64: 1715–1721.
2. Siebenhaar F, Weller K, Mlynek A, Magerl M, Altrichter S, Vieira Dos Santos R, et al. Acquired cold urticaria: clinical picture and update on diagnosis and treatment. Clin Exp Dermatol 2007; 32: 241–245.
3. Gaig P, Olona M, Muñoz Lejarazu D, Caballero MT, Domínguez FJ, Echechipia S, et al. Epidemiology of urticaria in Spain. J Investig Allergol Clin Immunol 2004; 14: 214–220.
4. Confino-Cohen R, Chodick G, Shalev V, Leshno M, Kimhi O, Goldberg A. Chronic urticaria and autoimmunity: associations found in a large population study. J Allergy Clin Immunol 2012; 129: 1307–1313.
5. Wanderer AA, Grandel KE, Wasserman SI, Farr RS. Clinical characteristics of cold-induced systemic reactions in acquired cold urticaria syndromes: recommendations for prevention of this complication and a proposal for a diagnostic classification of cold urticaria. J Allergy Clin Immunol 1986; 78: 417–423.
6. Wanderer AA, Hoffman HM. The spectrum of acquired and familial cold-induced urticaria/urticaria-like syndromes. Immunol Allergy Clin North Am 2004; 24: 259–286.
7. Kaplan AP, Gray L, Shaff RE, Horakora Z, Beavon MA. In vivo studies of mediator release in cold urticaria and cholinergic urticaria. J Allergy Clin Immunol 1975; 55: 394–402.
8. Garotalo J, Hauber T, Kaplan AP. Idiopathic cold urticaria: in-vitro demonstration of histamine release upon challenge of skin biopsies. N Engl J Med. 1981; 305: 1074–1077.
9. Capulong MC, Tomikawa M, Tahara K, Akasawa A, Iikura Y. Cold stimulation test and histamine release in primary acquired cold urticaria. Int Arch Allergy Immunol 1997; 114: 400–403.
10. Nuutinen P, Harvima IT, Ackermann L. Histamine, but not leukotriene C4, is an essential mediator in cold urticaria wheals. Acta Derm Venereol 2007; 87: 9–13.
11. Grandel KE, Farr RS, Wanderer AA, Eisenstadt TC, Wasserman SI. Association of platelet-activating factor with primary acquired cold urticaria. N Engl J Med 1985; 313: 405–409.
12. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Gimenez-Arnau A, et al. EAACI/GA(2) LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009; 64: 1417–1426.
13. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Gimenez-Arnau A, et al. EAACI/GA(2) LEN/EDF/WAO guideline: management of urticaria. Allergy 2009; 64: 1427–1443.
14. Kajiwara N, Sasaki T, Bradding P, Cruse G, Sagara H, Ohmori K, et al. Activation of human mast cells through the platelet-activating factor receptor. J Allergy Clin Immunol 2010; 125: 1137–1145.
15. Krause K, Ardelean E, Kebler B, Magerl M, Metz M, Siebenhaar F, et al. Causes, triggers and mechanisms of physical urticarias – insights from cold-contact urticaria. Adv Psor Inflamm Skin Dis 2010; 1: 99–104.
16. Krause K, Zuberbier T, Maurer M. Modern approaches to the diagnosis and treatment of cold contact urticaria. Curr Allergy Asthma Rep 2010; 10: 243–249.
17. Siebenhaar F, Staubach P, Metz M, Magerl M, Jung J, Maurer M. Peltier effect-based temperature challenge: an improved method for diagnosing cold urticaria. J Allergy Clin Immunol 2004; 114: 1224–1225.
18. Siebenhaar F, Degener F, Zuberbier T, Martus P, Maurer M. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J Allergy Clin Immunol 2009; 123: 672–679.
19. Mlynek A, Magerl M, Siebenhaar F, Weller K, Vieira Dos Santos R, Zuberbier T, et al. Results and relevance of critical temperature threshold testing in patients with acquired cold urticaria. Br J Dermatol 2009; 162: 198–200.
20. Juhlin L, de Vos C, Rihoux JP. Inhibiting effect of cetirizine on histamine-induced and 48/80-induced wheals and flares, experimental dermographism, and cold-induced urticaria. J Allergy Clin Immunol 1987; 80: 599–602.
21. Juhlin L. Inhibition of cold urticaria by desloratadine. J Dermatolog Treat 2004; 15: 51–59.
22. Villas Martínez F, Contreras FJ, LópezCazaña JM, López Serrano MC, Martínez Alzamora F. A comparison of new nonsedating and classical antihistamines in the treatment of primary acquired cold urticaria (ACU). J Investig Allergol Clin Immunol 1992; 2: 258–262.
23. Dubertret L, Pecquet C, Murrieta-Aguttes M, Leynadier F. Mizolastine in primary acquired cold urticaria. J Am Acad Dermatol 2003; 48: 578–583.
24. Tosoni C, Lodi-Rizzini F, Bettoni L, Toniati P, Zane C, Capezzera R, et al. Cinnarizine is a useful and well-tolerated drug in the treatment of acquired cold urticaria (ACU). Eur J Dermatol 2003; 13: 54–56.
25. Van Cauwenberge P, De Belder T, Sys L. A review of the second-generation antihistamine ebastine for the treatment of allergic disorders. Expert Opin Pharmacother 2004; 5: 1807–1813.
26. Magerl M, Schmolke J, Siebenhaar F, Zuberbier T, Metz M, Maurer M. Acquired cold urticaria symptoms can be safely prevented by ebastine. Allergy 2007; 62: 1465–1468.
27. Di Leo E, Nettis E, Cassano N, Foti C, Delle Donne P, Vena GA, et al. Treatment of acquired cold urticaria with rupatadine. Allergy 2009; 64: 1387–1388.
28. Metz M, Scholz E, Ferran M, Izquierdo I, Gimenez-Arnau A, Maurer M. Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. Ann Allergy Asthma Immunol 2010; 104: 86–92.
29. Kaplan AP. Treatment of cold urticaria. Curr Allergy Asthma Rep 2010; 10: 223–224.
30. Krause K, Spohr A, Zuberbier T, Church MK, Maurer M. Up-dosing with bilastine results in improved effectiveness in cold contact urticaria. Allergy 2013; 68: 921–928.
31. Buss YL, Sticherling M. Cold urticaria; disease course and outcome – an investigation of 85 patients before and after therapy. Br J Dermatol 2005; 153: 440–441.
32. Weinstein ME, Wolff AH, Bielory L. Efficacy and tolerability of second- and third-generation antihistamines in the treatment of acquired cold urticaria: a meta-analysis. Ann Allergy Asthma Immunol 2010; 104: 518–522.
33. Katsarou-Katsari A, Makris M, Lagogianni E, Gregoriou S, Theoharides T, Kalogeromitros D. Clinical features and natural history of acquired cold urticaria in a tertiary referral hospital: a 10-year prospective study. J Eur Acad Dermatol Venereol 2008; 22: 1405–1411.
34. Magerl M, Pisarevskaja D, Staubach P, Martus P, Church MK, Maurer M. Critical temperature threshold measurement for cold urticaria: a randomized controlled trial of H(1)-antihistamine dose escalation. Br J Dermatol 2012; 166: 1095–1099.
35. Nettis E, Delle Donne P, Di Leo E, Calogiuri GF, Ferrannini A, Vacca A. Rupatadine for the treatment of urticaria. Expert Opin Pharmacother 2013; 14: 1807–1813.
36. Metz M, Altrichter S, Ardelean E, Kessler B, Krause K, Magerl M, et al. Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria. Int Arch Allergy Immunol 2011; 154: 177–180.